Genomic Testing Cooperative
GTC offers genomic profiling of DNA, and RNA for both myeloid and lymphoid neoplasms. Our cooperative model allows us to partner with laboratories, hospitals, oncology practices and medical professionals to internalize our NGS testing paired with AI software to standardize testing and analysis. GTC’s testing is NY state approved and covered by Medicare and insurance. Our RNA sequencing capabilities go beyond just the detection of fusions and include alternative splicing, gene expression and more.
GTC offers advanced genomic profiling of DNA/RNA for hematologic cancers. GTC's Liquid Trace is a comprehensive LBx analyzing cfDNA and cfRNA that will reduce the need for bone marrow biopsies. Our co-op model allows us to support labs to internalize NGS testing, while providing bioinformatics and reporting. We do all of the R&D work to keep the assays up to date with the science and disperse that to our co-op members. GTC also can operate as traditional reference lab. We have a TAT of 5-10 days